Abnormal lipid peroxidation in patients with sleep apnoea.

The prevalence of cardiovascular diseases is increased in patients with the obstructive sleep apnoea syndrome (OSAS). The fall and rise of arterial oxygenation that follows each apnoea may increase lipid peroxidation and contributes to explaining this association. In the present study, the authors determined lipid peroxidation in patients with OSAS and the effect of treatment with continuous positive airway pressure (CPAP). Fourteen male patients with severe OSAS (59+/-5 apnoea x h(-1)) (+/-SEM) and 13 healthy nonsmoking, male volunteers of similar age were studied. Patients were studied at diagnosis and after treatment with CPAP for more than 1 yr (>4 h x night(-1)). A venous blood sample was obtained early in the morning after fasting all night. In patients with OSAS, a sample before and during sleep was also obtained. Low density lipoprotein (LDL) particles were isolated by sequential ultracentrifugation. Their level of oxidation was determined by the thiobarbituric acid assay (TBARs), and their susceptibility to oxidation by the lag phase measurement. Patients with OSAS showed higher TBARs (28.1+/-2.8 versus 20.0+/-1.8 nmol x malondialdehyde x mgLDL protein(-1), p=0.02) and shorter lag phase values (83.8+/-3.4 versus 99.7+/-3.4 min, p=0.005) than controls. These differences were not due to the smoking status of the patient. Likewise, these values did not change significantly throughout the night yet, the lag phase value was significantly improved by treatment with CPAP (124.9+/-8.5 min; p<0.001). These results indicate that obstructive sleep apnoea syndrome is associated with abnormal lipid peroxidation and that this is improved by chronic use of Continuous positive airway pressure. These results can contribute towards explaining the high prevalence of cardiovascular diseases seen in Obstructive sleep apnoea syndrome.

[1]  L. Bartoshuk,et al.  On Self Reports , 2002 .

[2]  T. Lehtimäki,et al.  Autoantibodies against Oxidised Low-Density Lipoprotein in Patients with Obstructive Sleep Apnoea , 1999, Clinical Chemistry and Laboratory Medicine.

[3]  M. Kryger,et al.  Susceptibility of LDL to oxidative stress in obstructive sleep apnea. , 1998, Sleep.

[4]  David Watts.  Apnea , 1997, The Lancet.

[5]  Mechanism of apnea lengthening across the night in obstructive sleep apnea. , 1996, American journal of respiratory and critical care medicine.

[6]  E. Fletcher,et al.  The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. , 1995, The American journal of medicine.

[7]  M. Cosio,et al.  Changes in obstructive sleep apnea characteristics through the night. , 1994, Chest.

[8]  I. Jialal,et al.  Effects of antioxidants and fatty acids on low-density-lipoprotein oxidation. , 1994, The American journal of clinical nutrition.

[9]  M. Kendall,et al.  The oxidation hypothesis of atherosclerosis , 1994, The Lancet.

[10]  J. Witztum,et al.  The oxidation hypothesis of atherosclerosis , 1994, The Lancet.

[11]  Olli Polo,et al.  Pathogenesis of obstructive sleep apnoea/hypopnoea syndrome , 1994, The Lancet.

[12]  L. Peterson,et al.  High prevalence of hypertension in sleep apnea patients independent of obesity. , 1994, American journal of respiratory and critical care medicine.

[13]  J. Hedner,et al.  Speculations on the interaction between vascular disease and obstructive sleep apnea , 1994 .

[14]  C. Zwillich,et al.  Possible atherogenic effects of hypoxia during obstructive sleep apnea. , 1993, Sleep.

[15]  T. V. Berkel,et al.  Susceptibility of low-density lipoproteins to oxidation in coronary bypass patients , 1992, The Lancet.

[16]  P. Demacker,et al.  Improved measurement of low-density-lipoprotein susceptibility to copper-induced oxidation: application of a short procedure for isolating low-density lipoprotein. , 1992, Clinical chemistry.

[17]  A. Hamsten,et al.  Susceptibility to low-density lipoprotein oxidation and coronary atherosclerosis in man , 1992, The Lancet.

[18]  D. Hillman,et al.  Association of sleep apnoea with myocardial infarction in men , 1990, The Lancet.

[19]  D. Janero,et al.  Malondialdehyde and thiobarbituric acid-reactivity as diagnostic indices of lipid peroxidation and peroxidative tissue injury. , 1990, Free radical biology & medicine.

[20]  H. Esterbauer,et al.  Continuous Monitoring of in Vztro Oxidation of Human Low Density Lipoprotein , 2009 .

[21]  J L Witztum,et al.  Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. , 1989, The New England journal of medicine.

[22]  H. Esterbauer,et al.  Continuous monitoring of in vitro oxidation of human low density lipoprotein. , 1989, Free radical research communications.

[23]  D. Crowell,et al.  Identifying sleep apnea from self-reports. , 1988, Sleep.

[24]  J. Kaprio,et al.  Snoring as a risk factor for ischaemic heart disease and stroke in men. , 1987, British medical journal.

[25]  ColinE. Sullivan,et al.  REVERSAL OF OBSTRUCTIVE SLEEP APNOEA BY CONTINUOUS POSITIVE AIRWAY PRESSURE APPLIED THROUGH THE NARES , 1981, The Lancet.

[26]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[27]  R. Havel,et al.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. , 1955, The Journal of clinical investigation.